市場調査レポート
商品コード
1467560
ラボ用遠心分離機の市場レポート:製品タイプ、モデルタイプ、ローターデザイン、使用目的、用途、最終用途、地域別、2024~2032年Laboratory Centrifuge Market Report by Product Type, Model Type, Rotor Design, Intended Use, Application, End-User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ラボ用遠心分離機の市場レポート:製品タイプ、モデルタイプ、ローターデザイン、使用目的、用途、最終用途、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 134 Pages
納期: 2~3営業日
|
世界のラボ用遠心分離機市場規模は、2023年に17億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて3.8%の成長率(CAGR)を示し、2032年には24億米ドルに達すると予測しています。がんや心血管疾患などの慢性疾患やウイルス感染症の蔓延の拡大、薬剤規制政策の強化に向けた各国の政府の取り組み、さまざまなセグメントでの遠心分離機の幅広い利用などが、市場を後押しする主要要因となっています。
ラボ用遠心分離機は、密度、質量、その他の物理的特性に基づいてサンプル内の物質を分離するために、科学や医療の現場で使用される特殊な装置です。この多目的な装置は、中心軸の周りで試料を急速に回転させることによって発生する遠心力を利用しています。実験室用遠心分離機には、少量のサンプルを扱う微量遠心分離機や、より大きなサンプルサイズと量に対応できる大型の床置き型遠心分離機など、さまざまなタイプがあります。さまざまなチューブサイズやサンプル量に対応できるよう、さまざまなデザインのローターが装備されています。これらの遠心分離機は、異種サンプルの効率的かつ精密な分離を可能にすることで、調査、診断、さまざまな科学的調査の進展において極めて重要な役割を果たしています。
がん、心血管疾患(CVDs)、糖尿病、腎臓・肝臓疾患、肝炎、マラリア、ヒト免疫不全ウイルス(HIV)など、慢性疾患やウイルス感染の蔓延が世界市場を牽引しています。これを支えているのは、このような健康状態に罹患しやすい高齢化人口の増加と、個別化された治療・診断に対する嗜好の高まりです。さらに、薬事規制政策の強化、臨床研究の標準化、償還政策の改善に対する各国の政府の取り組みが、市場の拡大に寄与しています。また、大学、研究機関、学術研究所は、遠心分離機を含む研究用機器の主要ユーザーです。これが市場を支えています。研究資金や学術活動の拡大に伴い、遠心分離機の需要も増加しています。さらに、食品製造、化粧品、製造業などさまざまな業界では、一貫した製品品質を確保するために品質管理対策が必要です。遠心分離機は、原材料や完成品を分離・分析するためにこれらのセグメントで採用されており、市場を牽引しています。
バイオテクノロジーと製薬研究の成長
これらの産業は技術革新の最前線にあり、病気を理解し、新しい治療法を開発し、医療の成果を改善するための新しい方法を常に模索しています。ラボ用遠心分離機は、さまざまな生物学的成分の正確な分離、単離、分析を可能にすることで、これらの追求において極めて重要な役割を果たしています。バイオテクノロジーの領域では、研究者は複雑な細胞プロセス、タンパク質相互作用、遺伝的メカニズムを掘り下げています。これらの複雑性を解明するためには、特定の生体分子や細胞構造を効果的に分離・濃縮できるツールが必要です。実験室の遠心分離機は、質量と密度に基づいて物質を分離するために遠心力を加えることで、このニーズを満たしています。これは、ゲノミクス、プロテオミクス、分子生物学など、核酸、タンパク質、細胞小器官を分離することが疾患経路の解明や標的治療の開発に不可欠なセグメントの研究に不可欠です。
医療における診断の進歩
遠心分離は臨床試験室における基本的なステップであり、血液成分、尿沈渣、その他の体液の分離を助ける。慢性疾患や感染症の流行が高まる中、正確でタイムリーな診断情報は効果的な患者管理に不可欠です。遠心分離機の設計における技術的進歩は、処理時間の短縮、サンプル処理能力の向上、使いやすさの向上をもたらしました。さらに、遠心分離機とフローサイトメトリーや分子診断などの他の診断技術との統合により、患者サンプルの包括的かつ多角的な分析が可能になりました。医療業界が疾患の早期発見と個別化治療戦略を重視し続ける中、診断精度と効率を高める高度な試験用遠心機に対する需要は、依然として市場の重要な促進要因となっています。
バイオプロセスとバイオマニュファクチャリングへの注力
特にバイオ医薬品業界は、細胞培養の採取、タンパク質の精製、細胞破片の除去など、生産のさまざまな段階で遠心分離機に依存しています。モノクローナル抗体、ワクチン、治療用タンパク質などのバイオ医薬品の需要は増加傾向にあり、スケーラブルで効率的な製造プロセスが必要とされています。大容量処理、穏やかな分離メカニズム、容易な拡大性を提供する遠心分離機は、バイオプロセス施設の要求を満たすために求められています。さらに、再生医療と細胞治療の出現により、デリケートで貴重な細胞マテリアルを取り扱うことができる特殊な遠心分離機の必要性が高まっています。ラボ用遠心分離機市場は、バイオプロセシングのワークフローを最適化し、製品ロスを最小限に抑え、一貫した製品品質を確保する技術を革新することでこうした需要に応えており、バイオマニュファクチャリングの進歩に大きく貢献しています。
The global laboratory centrifuge market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 3.8% during 2024-2032. The growing prevalence of chronic diseases and viral infections, including cancer, and cardiovascular diseases, governmental efforts across various countries to enhance medication regulatory policies, and wide utilization of centrifuges across various sectors are some of the major factors propelling the market.
A laboratory centrifuge is a specialized instrument used in scientific and medical settings to separate substances within a sample based on their density, mass, and other physical properties. This versatile device employs centrifugal force, which is generated by rapidly rotating the sample around a central axis. Laboratory centrifuges come in various types, such as microcentrifuges, which handle small volumes of samples, and larger floor-standing centrifuges capable of accommodating larger sample sizes and quantities. They are equipped with rotors of different designs to accommodate various tube sizes and sample volumes. They play a pivotal role in advancing research, diagnostics, and various scientific investigations by enabling efficient and precise separation of heterogeneous samples.
The growing prevalence of chronic diseases and viral infections, including cancer, cardiovascular diseases (CVDs), diabetes, kidney and liver disorders, hepatitis, malaria, and human immunodeficiency virus (HIV), is driving the global market. This is supported by the growing aging population, which is more susceptible to such health conditions, and the rising preference for personalized medical treatments and diagnostics. Furthermore, governmental efforts across various countries to enhance medication regulatory policies, standardize clinical studies, and refine reimbursement policies are contributing to the expansion of the market. Besides, universities, research institutions, and academic laboratories are key users of laboratory equipment, including centrifuges. This is supporting the market. As research funding and academic activities grow, the demand for centrifuges also increases. Furthermore, various industries such as food production, cosmetics, and manufacturing require quality control measures to ensure consistent product quality. Centrifuges are employed in these sectors to separate and analyze raw materials and finished products, thus impelling the market.
Growing Biotechnology and Pharmaceutical Research
These industries are at the forefront of innovation, constantly seeking new ways to understand diseases, develop novel therapies, and improve healthcare outcomes. Laboratory centrifuges play a pivotal role in these pursuits by enabling precise separation, isolation, and analysis of various biological components. In the realm of biotechnology, researchers are delving into intricate cellular processes, protein interactions, and genetic mechanisms. To unravel these complexities, they require tools that can effectively separate and concentrate specific biomolecules and cellular structures. Laboratory centrifuges fulfill this needs by applying centrifugal force to segregate substances based on their mass and density. This is essential for studies in fields, such as genomics, proteomics, and molecular biology, where isolating nucleic acids, proteins, and organelles is critical for gaining insights into disease pathways and developing targeted therapies.
Diagnostic Advancements in Healthcare
Centrifugation is a fundamental step in clinical laboratories, aiding in the separation of blood components, urine sediments, and other bodily fluids. With the rising prevalence of chronic diseases and infections, accurate and timely diagnostic information is essential for effective patient management. Technological advancements in centrifuge design have led to instruments with faster processing times, better sample handling capabilities, and improved ease of use. Moreover, the integration of centrifuges with other diagnostic technologies, such as flow cytometry and molecular diagnostics, enables comprehensive and multi-dimensional analysis of patient samples. As the healthcare industry continues to emphasize early disease detection and personalized treatment strategies, the demand for advanced laboratory centrifuges that enhance diagnostic accuracy and efficiency remains a significant market driver.
Focus on Bioprocessing and Biomanufacturing
The biopharmaceutical industry, in particular, relies on centrifuges for various stages of production, including cell culture harvesting, protein purification, and cell debris removal. The demand for biopharmaceutical products, such as monoclonal antibodies, vaccines, and therapeutic proteins, is on the rise, necessitating scalable and efficient manufacturing processes. Centrifuges that offer large-capacity processing, gentle separation mechanisms, and easy scalability are sought after to meet the demands of bioprocessing facilities. Additionally, the emergence of regenerative medicine and cell therapy has driven the need for specialized centrifuges capable of handling delicate and valuable cellular materials. The laboratory centrifuge market responds to these demands by innovating technologies that optimize bioprocessing workflows, minimize product loss, and ensure consistent product quality, thus contributing significantly to the advancement of biomanufacturing practices.
IMARC Group provides an analysis of the key trends in each segment of the global laboratory centrifuge market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, model type, rotor design, intended use, application and end-user.
Equipment
Multipurpose Centrifuges
Microcentrifuges
Ultracentrifuges
Minicentrifuges
Others
Accessories
Rotors
Tubes
Centrifuge Bottles
Buckets
Plates
Others
Equipment dominates the market
The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment (multipurpose centrifuges, microcentrifuges, ultracentrifuges, minicentrifuges, and others) and accessories (rotors, tubes, centrifuge bottles, buckets, plates, and others). According to the report, equipment represented the largest segment.
Benchtop Centrifuges
Floor-Standing Centrifuges
Benchtop centrifuges hold the largest share in the market
A detailed breakup and analysis of the market based on the model type has also been provided in the report. This includes benchtop centrifuges, and floor-standing centrifuges. According to the report, benchtop centrifuges accounted for the largest market share.
Fixed-Angle Rotors
Swinging-Bucket Rotors
Vertical Rotors
Others
Fixed angle rotors hold the largest share in the market
A detailed breakup and analysis of the market based on the rotor design has also been provided in the report. This includes fixed-angle rotors, swinging-bucket rotors, vertical rotors, and others. According to the report, fixed angle rotors accounted for the largest market share.
General Purpose Centrifuges
Clinical Centrifuges
Preclinical Centrifuges
General purpose centrifuges hold the largest share in the market
A detailed breakup and analysis of the market based on the intended use has also been provided in the report. This includes general purpose centrifuges, clinical centrifuges, and preclinical centrifuges. According to the report, general purpose centrifuges accounted for the largest market share.
Diagnostics
Microbiology
Cellomics
Genomics
Proteomics
Blood Component Separation
Others
Diagnostics hold the largest share in the market
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes diagnostics, microbiology, cellomics, genomics, proteomics, blood component separation, and others. According to the report, diagnostics accounted for the largest market share.
Hospitals
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Hospitals hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospitals, biotechnology and pharmaceutical company, and academic and research institutions. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest laboratory centrifuge market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.
Andreas Hettich GmbH & Co. KG
Becton, Dickinson and Company
Danaher Corporation
Eppendorf AG
GTCR LLC
HERMLE Labortechnik
Koki Holdings Co. Ltd.
Kubota Corporation
NuAire
QIAGEN N.V.
Sanofi Pasteur
Sartorius
Sigma Laborzentrifugen GmbH
Thermo Fisher Scientific Inc.